; (iii) conducting clinical trials; (iv) seeking Food and Drug Administration approval for drugs to treat addiction; (v) marketing the drug for the treatment of addiction; (vi) urging physicians to use the drug in the treatment of addiction; and (vii) encouraging insurance companies to reimburse the cost of the drug for the treatment of addiction. 1014. Authorization of appropriations There are authorized to be appropriated to carry out this chapter, except as otherwise specified, to remain available until expended, $18,400,000 for each of fiscal years 2019 through 2023. II High Intensity Drug Trafficking Areas Program 1021. High intensity drug trafficking areas program (a) Establishment (1) In general There is established in the Office a program to be known as the High Intensity Drug Trafficking Areas Program (in this section referred to as the Program ). (2) Purpose The purpose of the Program is to reduce drug trafficking and drug production in the United States by— (A) facilitating cooperation among Federal, State, local, and Tribal law enforcement agencies to share information and implement coordinated enforcement activities; (B) enhancing law enforcement intelligence sharing among Federal, State, local, and Tribal law enforcement agencies; (C) providing reliable law enforcement intelligence to law enforcement agencies needed to design effective enforcement strategies and operations